not the cheapest biotech on asx Its at net cash backing - net asset backing - why it hasnt risne the market thinks it has no chance. So its one of the more expensive priced non performers on teh ASX biotechs at present.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
-0.030(1.74%) |
Mkt cap ! $286.9M | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.72 | $1.68 | $33.63K | 19.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1591 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.71 | 10000 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |